#accesstomedicines — Public Fediverse posts

A failed attempt to describe life in Gaza during the “ceasefire”

https://fed.brid.gy/r/https://electronicintifada.net/content/failed-attempt-describe-life-gaza-during-ceasefire/51666

https://www.europesays.com/ch/135189/ Fortune includes Novartis in 2026 Change The World List for malaria program #AccessToMedicines #Antimalarial #GlobalHealth #Innovation #Malaria #Novartis #NovartisPharmaceuticals #ResearchAndDevelopment #SocialImpact #Sustainability

Medicine shortages amid siege leave people in peril

https://fed.brid.gy/r/https://electronicintifada.net/content/medicine-shortages-amid-siege-leave-people-peril/51383

Millions still lack access to life-saving medicines, not because science failed, but because patents, prices, and politics get in the way. This deep dive unpacks how countries have used (and sometimes avoided) TRIPS flexibilities over the past 25 years to break monopolies,

Read more: https://gh.bmj.com/content/11/1/e021481

#AccessToMedicines #TRIPS #PublicHealth #MedicineQuality #GlobalHealth #HealthEquity #GenericMedicines #PharmaPolicy #IPandHealth #Quamed

Johnson & Johnson announces deal to cut drug prices, new Pennsylvania manufacturing site | Berks Regional News

NEW BRUNSWICK, Nj. – Johnson & Johnson is the latest U.S. drugmaker to announce …
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #accesstomedicines #celltherapy #drugproductmanufacturingfacility #Health #joaquinduato #Johnson&Johnson #medicationcosts #MERCK&CO #Pennsylvania #Sanofi #TrumpAdministration #TrumpRx #trumprx.com
https://www.newsbeep.com/us/398424/

Israel massacres children in Gaza tent shelters

https://fed.brid.gy/r/https://electronicintifada.net/blogs/nora-barrows-friedman/israel-massacres-children-gaza-tent-shelters

Broader access urged for affordable HIV drug
#Health #HIV #Lenacapavir #GlobalHealth #HealthEquity #AccessToMedicines #HIVAIDS #PublicHealth #EndAIDS #AffordableMedicine #MiddleIncomeCountries
https://the-14.com/broader-access-urged-for-affordable-hiv-drug/

Faster innovative medicines access for Irish patients is possible, says pharma report https://www.euractiv.com/section/health-consumers/news/faster-innovative-medicines-access-for-irish-patients-is-possible-says-pharma-report/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #EUPharmaPackage #IPHA #Ireland

Flu cases skyrocket in Poland, causing medicine shortages, rising fatalities https://www.euractiv.com/section/health-consumers/news/flu-cases-skyrocket-in-poland-causing-medicine-shortages-rising-fatalities/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #Flu #Poland #vaccination

Dutch struggling to provide patients with quick, affordable access to innovative medicines https://www.euractiv.com/section/health-consumers/news/dutch-struggling-to-provide-patients-with-quick-affordable-access-to-innovative-medicines/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #cancer #InnovativeMedicines #TheNetherlands

Swedish drug agency’s new pricing model surprises, concerns patient and pharma groups https://www.euractiv.com/section/health-consumers/news/swedish-drug-agencys-new-pricing-model-surprises-concerns-patient-and-pharma-groups/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #drugpricing #EUPharmaPackage #Sweden

What is Hormone Replacement Therapy? (Download and archive this video.)

A hormone is a chemical messenger made by your body to send signals to some or all body cells. Some hormones are made in other bodies or through chemical processes, like other medications.

HRT is a medical treatment for certain conditions, including menopause for some people, or precocious puberty for others.
(Mostly) Older men and women also use it to affirm their gender experiences.

HRT has certain side effects on your body. You may find these desirable or unpleasant.
Any medical intervention can have therapeutic effects and side effects. Different people experience different outcomes.

Do you want or need to biohack your hormone levels to affect your body?
Please learn more from your GP, family doctor, primary care provider, or another trusted clinician with access to your personal medical records.

Some of the waiting lists can be quite long, or involve more steps than you may expect. So ask early, please!

copy of links in video description: https://lgbtqia.space/@MxVerda/113876807351799423

https://nebula.tv/videos/lilyalexandre-diy-hormone-therapy-everything-i-can-legally-tell-you/

from the vid: gender affirming care is suicide prevention. It's also preventative care against diseases of despair.

#trans #TransUK #transgender #transgenderUK #TransgenderCrowdFund #LGBT #LGBTQ #LGBTQIA #LGBTQIA2S #medicine #medical #MedicalCare #MutualAid #information #info #detail #details #curiosity #intro #introduction #introductions #NHS #gender #gendered #genders #identity #autonomy #MedicalAutonomy #support #help #idea #ideas #medicines #AccessToMedicines #hormones #treatment #tx #diagnosis #dx #symptoms #sx #prescription #rx #patient #px #transHealth #TransHealthCare

Poland’s growing health access delays damned by latest benchmark report https://www.euractiv.com/section/health-consumers/news/polands-growing-health-access-delays-damned-by-latest-benchmark-report/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #HealthBudgets #healthcare #Poland

Sweden planning to increase patient medicine costs https://www.euractiv.com/section/health-consumers/news/sweden-planning-to-increase-patient-medicine-costs/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #EUPharmaPackage #Sweden

Bulgarian patients suing the state, seeking revolution in equal access to medicine https://www.euractiv.com/section/health-consumers/news/bulgarian-patients-suing-the-state-to-spark-revolution-in-equal-access-to-medicine/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #Bulgaria #EUPharmaPackage

Dutch trim medicines budget, but cause delayed access to new drugs, says pharma industry https://www.euractiv.com/section/health-consumers/news/dutch-reduced-spend-on-medicines-is-causing-delayed-access-to-new-drugs-says-pharma-industry/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #drugpricing #EUPharmaPackage #Netherlands

Czechia pushes for EU coordination in medicine stockpiling, offers resilient model for future https://www.euractiv.com/section/health-consumers/news/czechia-pushes-for-eu-coordination-in-medicine-stockpiling-offers-resilient-model-for-future/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #criticalmedicinesact #Czechia #EUPharmaPackage

Revising Europe’s pharmaceutical sector, future-proofing a healthier Europe https://www.euractiv.com/section/health-consumers/special_report/revising-europes-pharmaceutical-sector-future-proofing-a-healthier-europe/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #EUPharmaPackage #healthcare

Greek hospital drug funding crisis, pharma sector warns on patient access https://www.euractiv.com/section/health-consumers/news/greek-hospital-drug-funding-crisis-pharma-sector-warns-on-patient-access/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #EUPharmaPackage #Greece

Belgian university hospitals invest €14 million in new cell and gene therapy facility https://www.euractiv.com/section/health-consumers/news/belgian-university-hospitals-invest-e14-million-in-new-cell-and-gene-therapy-facility/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #AdvancedMedicines #Belgium #EUPharmaPackage

Bulgaria pitches fast domestic authorisation of innovative drugs to attract pharma firms https://www.euractiv.com/section/health-consumers/news/bulgaria-pitches-fast-domestic-authorisation-of-innovative-drugs-to-attract-pharma-firms/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #Bulgaria #EUPharmaPackage

Czech MEP urges EU to tackle pharma reliance, cut bureaucracy, curb monopolies [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/czech-mep-urges-eu-to-tackle-pharma-reliance-cut-bureaucracy-curb-monopolies/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #Czechia #EUPharmaPackage #OndřejDostál

Dutch combining herbal products and medicines without consulting GP, warns medicines board [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/dutch-combining-herbal-products-and-medicines-without-consulting-gp-warns-medicines-evaluation-board/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #EUPharmaPackage #herbalmedicines #TheNetherlands

New pharmacy prescribing roles in Ireland could alleviate overstretched doctors [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/new-pharmacy-prescribing-roles-in-ireland-could-alleviate-overstretched-doctors/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #EUPharmaPackage #healthcare #Ireland #medicines

Athens supports regulatory obligation for pricing and reimbursement, to ensure medicines access [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/athens-supports-regulatory-obligation-for-pricing-and-reimbursement-to-ensure-medicines-access/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #EUPharmaPackage #Greece

Study highlights EU’s fragmented access to new medicine [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/study-highlights-eus-fragmented-access-to-new-medicine/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #Bulgaria #EUPharmaPackage #Sweden

New wave of radioligand therapy triggers Belgium to launch action plan [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/new-wave-of-radioligand-therapy-triggers-belgium-to-launch-action-plan/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #Belgium #cancer #healthcare #RadioligandTherapy

Dutch Minister plans to implement new reimbursement system for high-cost medicine  [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/dutch-minister-plans-to-implement-new-reimbursement-system-for-high-cost-medicine/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #MedicinesQuality #Medicinesreimbursement

Bulgaria extends ban on exports of insulin, antibiotics for children [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/bulgaria-extends-ban-on-exports-of-insulin-antibiotics-for-children/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #Bulgaria #Criticalmedicalsupplies

Massive stockpiling of medicines impacts single market, increases patient risks, warns EU coalition [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/massive-stockpiling-of-medicines-impacts-single-market-increases-patient-risks-warns-eu-coalition/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #EUPharmaPackage #Germany #singlemarket

Lower innovative drug costs not being passed on by pharma firms, say Dutch researchers [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/lower-innovative-drug-costs-not-being-passed-on-to-society-by-pharma-firms-say-dutch-researchers/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #EUPharmaPackage #TheNetherlands

Focus on national competence and drug prices in EU pharma package, says Bulgaria [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/focus-on-national-competence-and-drug-prices-in-eu-pharma-package-says-bulgaria/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #Bulgaria #EUPharmaPackage

Poland’s medical innovation advances despite ongoing challenges, report shows [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/polands-medical-innovation-advances-despite-ongoing-challenges-report-shows/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #Poland

Czech clinical trials lead with 40% increase in cancer drug studies [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/cancer-drugs-most-frequently-studied-in-czech-clinical-trials/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #biomedicalresearch #Czechia

Swedish neurologists warn ALS patients may have to self-pay for new gene therapy [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/swedish-neurologists-warn-als-patients-may-have-to-pay-for-new-gene-therapy/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #pharmacy #Sweden

Realising the potential of HTA Reform [Promoted content] https://www.euractiv.com/section/health-consumers/opinion/realising-the-potential-of-hta-reform/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #healthcare #HTA #Innovation #lifesciences

Inclusivity, transparency, delivery – navigating the EU’s new Health Technology Assessment Regulation (HTAR) https://www.euractiv.com/section/health-consumers/news/inclusivity-transparency-delivery-navigating-the-eus-new-health-technology-assessment-regulation-htar/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #EUPharmaPackage #healthcare #promoted

New article: 'The Gewirthian Needs-Based Hierarchy: A Concept for Prioritising Conflicting Norms in International Law' by Marc A. Stuhldreier, Nordic Journal of Human Rights:
https://www.tandfonline.com/doi/full/10.1080/18918131.2023.2229155

#internationallaw
#accesstomedicines
#righttohealth
#legalhierarchy
#treatylaw
#IP
#patentrights
#TRIPS
#gewirth
#humanrights
#WTO

‼️ In France, medicine shortages shot up 20-fold, in Spain the figure has gone up 12x in less than 20 years. We need solutions including pharma companies having to submit shortage prevention plans @[email protected] @[email protected] #AccessToMedicines. More here: https://www.beuc.eu/news/surveys-show-medicine-shortages-hit-consumers-hard-across-europe

Consumers think it's time to rebalance things when it comes to the outrageous prices we sometimes pay for medicines & the massive profits pharma companies make selling them. @[email protected]: new pharma legislation must sort this out https://www.beuc.eu/news/what-consumers-make-medicine-prices-today-research-results #EUPharma #AccessToMedicines

Is it right that pharma companies make huge profits on medicines which received lots of public money investment? Here's what consumers think, ahead of new EU legislation expected in March this year https://www.beuc.eu/news/what-consumers-make-medicine-prices-today-research-results #AccessToMedicines #EUPharma

New BEUC research provides a snapshot of what consumers in Italy, Spain and the Netherlands think of medicine prices. EU lawmakers need to know this as they prepare to overhaul #EUPharma legislation next year. https://www.beuc.eu/news/what-consumers-make-medicine-prices-today-research-results #AccessToMedicines

Through our focus groups, we learnt that consumers...

1⃣ highly value medicines as essential goods.

2⃣ do not approve of excessive pharma profits when the state has contributed to R&D.

Find out the other conclusions here: https://www.beuc.eu/news/what-consumers-make-medicine-prices-today-research-results #AccessToMedicines #EUPharma

During 2020-22 I connected with four colleagues to make the case for a waiver of intellectual property rights #TRIPSwaiver so more vaccines could be produced in times of catastrophic need. #VaccineEquity

I met two co-authors online. Intense outreach through seminars, hearings and debate followed. Work done by us and countless others might still transform #AccesstoMedicines

That was a gift of #Twitter.

Now I never see tweets from my collaborators. The damage to links unmade is incalculable.

I have just boosted a call from Health Justice Initiative in South Africa calling for donations on #givingtuesday

This might be new to some followers here but Fatima Hassan the founder is a tireless advocate for vaccine equity and public health. HJI could do with all our help, please consider donating.

https://healthjusticeinitiative.org.za/donate/

#VaccineEquity #Patents #AccesstoMedicines #GlobalHealth

Last week we released research about what consumers made of medicine prices. It's important @[email protected] pays close attention to these results ahead of releasing their #EUPharma legislation. https://www.beuc.eu/news/what-consumers-make-medicine-prices-today-research-results #AccessToMedicines

There's a reform of EU pharma legislation and if you're wondering what consumers currently think of medicine prices, we've got you covered: we conducted focus groups in three European countries. https://www.beuc.eu/news/what-consumers-make-medicine-prices-today-research-results #AccessToMedicines #EUPharma

We've published the results of focus groups with consumers about medicine prices. Ahead of an upcoming reform of pharma legislation at EU level, take a look at these interesting results:
https://www.beuc.eu/news/what-consumers-make-medicine-prices-today-research-results #AccessToMedicines #EUpharma

RESEARCH OUT | Consumers think there should be greater transparency on drug R&D costs, higher returns on public investment, and they disapprove of huge pharma profits when it comes to medicines. #EUPharma #AccessToMedicines Read more here: https://www.beuc.eu/news/what-consumers-make-medicine-prices-today-research-results